Every rule your marketing answers to.

Warrant reviews your marketing against 3,388 rules from 1,267 regulators across 11 countries. Every flag is cited to its source. Search the full library below.

Coverage includes the FTC, FDA, CFPB, SEC, FINRA, NCUA, FDIC, OCC, NAIC, and regulators from all 50 U.S. states, the European Union, Canada, and more.

Get a free homepage compliance scan

Regulation guides

Canada Health Product Advertising

In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity.

Food and Drugs Act ss. 3, 9, Sch. A.1; FDR C.01.044

Canadian Medical Device Advertising

Canadian medical device ads must not make treatment or cure claims for Schedule A.1 diseases to the public, misrepresent Health Canada authorization, or make false or misleading claims.

Food and Drugs Act ss. 3, 20, Sch. A.1

Health Canada Digital Therapeutics Advertising

Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.

Food and Drugs Act ss. 3, 20, Sch. A.1; Medical Devices Regulations s. 27

Health Canada Medical Device Advertising

Canadian medical device ads must stay within the licensed indication, not be misleading, and not promote treatment, prevention or cure of Schedule A.1 diseases to the public.

Food and Drugs Act ss. 3, 20, Sch. A.1; MDR s. 27

Browse by category

Browse by jurisdiction

Browse by regulator